119 related articles for article (PubMed ID: 3100799)
1. Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths.
Coy DH; Murphy WA; Lance VA; Heiman ML
J Med Chem; 1987 Jan; 30(1):219-22. PubMed ID: 3100799
[TBL] [Abstract][Full Text] [Related]
2. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells.
Coy DH; Hocart SJ; Murphy WA
Eur J Pharmacol; 1991 Nov; 204(2):179-85. PubMed ID: 1806385
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.
Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP
Peptides; 1994; 15(3):489-95. PubMed ID: 7937325
[TBL] [Abstract][Full Text] [Related]
4. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes.
Friedman AR; Ichhpurani AK; Brown DM; Hillman RM; Krabill LF; Martin RA; Zurcher-Neely HA; Guido DM
Int J Pept Protein Res; 1991 Jan; 37(1):14-20. PubMed ID: 1904406
[TBL] [Abstract][Full Text] [Related]
5. Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor.
Coy DH; Murphy WA; Lance VA; Heiman ML
Peptides; 1986; 7 Suppl 1():49-52. PubMed ID: 3092197
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid.
Sato K; Hotta M; Kageyama J; Chiang TC; Hu HY; Dong MH; Ling N
Biochem Biophys Res Commun; 1987 Dec; 149(2):531-7. PubMed ID: 3122736
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies on the N-terminal region of growth hormone releasing factor.
Coy DH; Murphy WA; Sueiras-Diaz J; Coy EJ; Lance VA
J Med Chem; 1985 Feb; 28(2):181-5. PubMed ID: 3918170
[TBL] [Abstract][Full Text] [Related]
8. Potent long-acting growth hormone releasing factor analogues.
Rivier J; Rivier C; Galyean R; Yammamoto G; Vale W
Ann N Y Acad Sci; 1988; 527():44-50. PubMed ID: 3133968
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.
Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622
[TBL] [Abstract][Full Text] [Related]
10. 1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs.
Kloosterman DA; Scahill TA; Hillman RM; Cleary DL; Kubiak TM
Pept Res; 1991; 4(2):72-8. PubMed ID: 1667740
[TBL] [Abstract][Full Text] [Related]
11. New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity.
Mezö I; Kovács M; Szöke B; Szabó EZ; Horváth J; Makara GB; Rappay G; Tamás J; Teplán I
J Endocrinol Invest; 1993 Nov; 16(10):793-8. PubMed ID: 8144853
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.
Izdebski J; Pinski J; Horvath JE; Halmos G; Groot K; Schally AV
Proc Natl Acad Sci U S A; 1995 May; 92(11):4872-6. PubMed ID: 7761415
[TBL] [Abstract][Full Text] [Related]
13. Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.
Hocart SJ; Murphy WA; Coy DH
J Med Chem; 1990 Jul; 33(7):1954-8. PubMed ID: 2141879
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor.
Ling N; Baird A; Wehrenberg WB; Ueno N; Munegumi T; Brazeau P
Biochem Biophys Res Commun; 1984 Sep; 123(2):854-61. PubMed ID: 6435620
[TBL] [Abstract][Full Text] [Related]
15. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
16. Potent long-acting alkylated analogs of growth hormone-releasing factor.
Murphy WA; Coy DH
Pept Res; 1988; 1(1):36-41. PubMed ID: 2908793
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological activity and conformational analysis of cyclic GRF analogs.
Felix AM; Heimer EP; Wang CT; Lambros TJ; Fournier A; Mowles TF; Maines S; Campbell RM; Wegrzynski BB; Toome V
Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952
[TBL] [Abstract][Full Text] [Related]
18. Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary.
Gaudreau P; Boulanger L; Abribat T
J Med Chem; 1992 May; 35(10):1864-9. PubMed ID: 1534126
[TBL] [Abstract][Full Text] [Related]
19. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
[TBL] [Abstract][Full Text] [Related]
20. Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs.
Stevenson CL; Friedman AR; Kubiak TM; Donlan ME; Borchardt RT
Int J Pept Protein Res; 1993 Dec; 42(6):497-503. PubMed ID: 8307680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
